Structural basis of HIV-1 resistance to AZT by excision

被引：0

作者：

Xiongying Tu

Kalyan Das

Qianwei Han

Joseph D Bauman

Arthur D Clark

Xiaorong Hou

Yulia V Frenkel

Barbara L Gaffney

Roger A Jones

Paul L Boyer

Stephen H Hughes

Stefan G Sarafianos

Eddy Arnold

机构：

[1] Center for Advanced Biotechnology and Medicine,Department of Chemistry and Biology

[2] Rutgers University,undefined

[3] HIV Drug Resistance Program,undefined

[4] National Cancer Institute–Frederick,undefined

[5] Present address: Department of Molecular Microbiology & Immunology,undefined

[6] University of Missouri,undefined

[7] Columbia,undefined

[8] Missouri,undefined

[9] USA.,undefined

来源：

Nature Structural & Molecular Biology | 2010年 / 17卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

AZT is a nucleoside analog drug that inhibits HIV-1 reverse transcriptase (RT). The viral enzyme can acquire AZT resistance by mutations that enhance the rate of ATP-mediated excision of the incorporated AZT. Now structural work illustrates how the AZT resistance mutations create a high-affinity binding site for ATP and thus promote excision.

引用

页码：1202 / 1209

页数：7

共 50 条

[41] Structural Basis of the Association of HIV-1 Matrix Protein with DNA
Cai, Mengli
Huang, Ying
Craigie, Robert
Clore, G. Marius
PLOS ONE, 2010, 5 (12):
[42] Structural basis of HIV-1 maturation inhibitor binding and activity
Sucharita Sarkar
Kaneil K. Zadrozny
Roman Zadorozhnyi
Ryan W. Russell
Caitlin M. Quinn
Alex Kleinpeter
Sherimay Ablan
Hamed Meshkin
Juan R. Perilla
Eric O. Freed
Barbie K. Ganser-Pornillos
Owen Pornillos
Angela M. Gronenborn
Tatyana Polenova
Nature Communications, 14
[43] Structural basis for HIV-1 DNA integration in the human genome
Fabrice Michel
Sylvia Eiler
Florence Granger
Jean-François Mouscadet
Marina Gottikh
Alexis Nazabal
Stéphane Emiliani
Richard Benarous
Dino Moras
Patrick Schultz
Marc Ruff
Retrovirology, 6 (Suppl 2)
[44] EVOLUTION OF HIV-1 GENOMES UNDER AZT SELECTION
METZKER, ML
LIU, XM
MILLER, M
LEWIS, DE
GIBBS, RA
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 194 - 194
[45] HIV-1 Protease: Structural Perspectives on Drug Resistance
Weber, Irene T.
Agniswamy, Johnson
VIRUSES-BASEL, 2009, 1 (03): : 1110 - 1136
[46] Resistance to HIV-1 integrase inhibitors: A structural perspective
Mouscadet, Jean-Francois
Delelis, Olivier
Marcelin, Anne-Genevieve
Tchertanov, Luba
DRUG RESISTANCE UPDATES, 2010, 13 (4-5) : 139 - 150
[47] LOSS OF SYNERGISTIC RESPONSE TO COMBINATIONS CONTAINING AZT IN AZT-RESISTANT HIV-1
COX, SW
ALBERT, J
WAHLBERG, J
UHLEN, M
WAHREN, B
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (07) : 1229 - 1234
[48] CLINICAL CORRELATES OF INVITRO HIV-1 RESISTANCE TO ZIDOVUDINE - RESULTS OF THE MULTICENTER CANADIAN AZT TRIAL
MONTANER, JSG
SINGER, J
SCHECHTER, MT
RABOUD, JM
TSOUKAS, C
OSHAUGHNESSY, M
RUEDY, J
NAGAI, K
SALOMON, H
SPIRA, B
WAINBERG, MA
AIDS, 1993, 7 (02) : 189 - 196
[49] Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50
Mittal, Seema
Bandaranayake, Rajinthna M.
King, Nancy M.
Prabu-Jeyabalan, Moses
Nalam, Madhavi N. L.
Nalivaika, Ellen A.
Yilmaz, Nese Kurt
Schiffer, Celia A.
JOURNAL OF VIROLOGY, 2013, 87 (08) : 4176 - 4184
[50] RESISTANCE OF HIV-1 TO AZT MIGHT ALSO INVOLVE THE CELLULAR EXPRESSION OF MULTIDRUG RESISTANCE P-GLYCOPROTEIN
ANTONELLI, G
TURRIZIANI, O
CIANFRIGLIA, M
RIVA, E
DONG, G
FATTOROSSI, A
DIANZANI, F
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) : 1839 - 1844

← 1 2 3 4 5 →